Werner Paul, Winter Martin, Mahr Stephané, Stelzmueller Marie-Elisabeth, Zimpfer Daniel, Ehrlich Marek
Department of Cardiac Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Bioengineering (Basel). 2024 Jul 31;11(8):775. doi: 10.3390/bioengineering11080775.
Surgery of the aortic arch remains a complex procedure, with neurological events such as stroke remaining its most dreaded complications. Changes in surgical technique and the continuous innovation in neuroprotective strategies have led to a significant decrease in cerebral and spinal events. Different modes of cerebral perfusion, varying grades of hypothermia, and a number of pharmacological strategies all aim to reduce hypoxic and ischemic cerebral injury, yet there is no evidence indicating the clear superiority of one method over another. While surgical results continue to improve, novel hybrid and interventional techniques are just entering the stage and the question of optimal neuroprotection remains up to date. Within this perspective statement, we want to shed light on the current evidence and controversies of cerebral protection in aortic arch surgery, as well as what is on the horizon in this fast-evolving field. We further present our institutional approach as a large tertiary aortic reference center.
主动脉弓手术仍然是一个复杂的手术,中风等神经事件仍然是其最可怕的并发症。手术技术的改变和神经保护策略的不断创新已导致脑和脊髓事件显著减少。不同的脑灌注模式、不同程度的低温以及多种药理学策略都旨在减少缺氧和缺血性脑损伤,但没有证据表明一种方法明显优于另一种方法。虽然手术结果不断改善,但新型杂交和介入技术刚刚进入该阶段,最佳神经保护问题仍然是最新的。在本观点声明中,我们希望阐明主动脉弓手术中脑保护的当前证据和争议,以及在这个快速发展的领域中即将出现的情况。我们还将介绍我们作为大型三级主动脉参考中心的机构方法。